Laninamivir (R-125489) is a very promising, novel influenza NA inhibitor with high potency and the ability to efficiently inhibit common oseltamivir-resistant viruses, including those with the ubiquitous His274Tyr substitution [32], [33], [34]. The gene discussed is XK; the disease is influenza.